HIKAL LTD (HIKAL.NS) Financials
HIKAL.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 23.9 billion | 12.5 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 23.9 billion | 12.5 billion |
HIKAL.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 579.4 million | ? |
| 2023-09-30 | 571.4 million | ? |
| 2023-06-30 | 554.6 million | ? |
| 2023-03-31 | 536.6 million | ? |
HIKAL.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 161.4 million |
| 2023-09-30 | 125.7 million |
| 2023-06-30 | 69.2 million |
| 2023-03-31 | 359.9 million |
HIKAL.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 361.0 million | - | - |
| 2023-09-30 | 486.0 million | 4.4 billion | 300000 |
| 2023-06-30 | 595.5 million | - | - |
| 2023-03-31 | 762.6 million | 4.9 billion | 2.3 million |
HIKAL.NS Shares Outstanding
HIKAL.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 1.2 billion | - | 618.1 million | - |
| 2023-06-30 | - | - | 596.3 million | - |
| 2023-03-31 | 3.0 billion | - | 1.2 billion | 2.4 million |
HIKAL.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 4.5 billion | 3.0 billion |
| 2023-09-30 | 4.3 billion | 2.1 billion |
| 2023-06-30 | 3.9 billion | 1.7 billion |
| 2023-03-31 | 5.4 billion | 2.8 billion |
HIKAL.NS
Price: ₹297.95
Dividend Yield: 0.42%
Forward Dividend Yield: 0.40%
Payout Ratio: 20.62%
Dividend Per Share: 1.20 INR
Earnings Per Share: 5.82 INR
P/E Ratio: 43.52
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 35.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 15
DGR3: -5.68%
DGR5: 11.07%
DGR10: 12.71%